Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 1 (1)

Trial Status

Not Yet Recruiting1
Recruiting1
Unknown1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07531511Not Yet Recruiting

SLC6A1-NDD Prospective Longitudinal Natural History Study

NCT06700811Phase 1RecruitingPrimary

Ketogenic Diet for Prevention of Epileptic Spasms in Infantile Onset Genetic Epilepsies

NCT06149663Unknown

Intermediate-Size Expanded Access Protocol (EAP) for LP352

Showing all 3 trials

Research Network

Activity Timeline